Project Grant R21NS135366

Award Date 9/16/23
Completion Date 8/31/25
Dollars Obligated $475K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research focused on understanding the role of microglia/macrophages in Lewy body disorders. The $231,826 award to Duquesne University, with sub-awards to the University of Pittsburgh and University of Pennsylvania, will investigate how the repopulation of...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $985,026 to The Trustees of the University of Pennsylvania to investigate the roles and mechanisms of epitranscriptomic regulation in the development and function of the mammalian nervous system. The research program has three interrelated projects focused on: 1)...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $694,134 to The Trustees of the University of Pennsylvania to support research on microglia replacement using engineered hematopoietic stem cells (HSCs) for the treatment of leukodystrophies, specifically globoid cell leukodystrophy (GLD or Krabbe disease). The key...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $204,156 to the Regents of the University of Michigan to study the role of macrophage subpopulations in nerve injury, inflammation, and regeneration. The research aims to understand the mechanisms by which specific macrophage subsets mediate efferocytosis, or the...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support a research project titled "A Comparative Analysis of OPC and Microglia Phagocytosis and its Relevance to Neurodegenerative Disease". The $516,756 award will enable the University of Massachusetts Medical School to conduct in-vitro and in-vivo studies...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $218,068 to The Children's Hospital of Philadelphia Research Institute to conduct research aimed at understanding the mechanisms of glial response and axon regeneration after spinal cord injuries. The 2-year award, from October 3, 2024 to December 31, 2026, will support...
This Project Grant award of $1,145,500 from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of California, San Diego supports research to understand the mechanisms by which hematopoietic stem cell transplantation can rescue Alzheimer's disease (AD) using the 5XFAD mouse model. The key objectives are to: Assess the impact of 5XFAD hematopoietic stem/progenitor cells (HSPC) on microgliosis and neuroinflammation in wild-type mice. Examine the hematopoietic lineage...
This $246,248 federal Project Grant awarded on December 1, 2024 by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research on the role of disrupted autophagy in the progression of Alzheimer's disease (AD) and related dementias. The principal investigator at The Trustees of the University of Pennsylvania will investigate how disturbances in the clearance of...
This Project Grant award from the National Institute on Aging's Aging Research federal grant program (CFDA 93.866) provides $871,419 to the University of Washington to conduct research on the role of microglia, the brain's immune cells, in the pathogenesis of Alzheimer's disease. The research aims to characterize molecular profiles and spatial organization of microglia across the adult age spectrum, both with and without Alzheimer's disease, through single-nucleus RNA sequencing of over 5,000...

This $475,369 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to better understand how microglia (the brain's resident macrophages) are programmed by the brain environment following transplantation.

The primary awardee, The Trustees of the University of Pennsylvania, will use single-cell RNA and ATAC sequencing to comprehensively characterize the regulatory mechanisms that cause transplanted macrophages to acquire a microglial identity over time. This highly controlled in vivo model will generate a detailed dataset on the environmental signals, transcription factors, and pathways responsible for microglial state changes. The researchers will also compare the programming of microglia versus peripheral macrophages after transplantation.

The project has a period of performance from September 16, 2023 to August 31, 2025 and includes a sub-award to The Children's Hospital of Philadelphia Research Institute to contribute expertise and capabilities. This research aims to fill key knowledge gaps about microglial regulation and identify potential therapeutic targets for brain diseases.

Generated 8/13/24, 6:03 AM